Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NRIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RARA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCNK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETD1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RSPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GADD45G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3BP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01588 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LONRF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASCL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on